Clinical Trials

Showing trials with last updates posted in 2025.

NCT04458909 | TERMINATED | PHASE3
15 participants

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2020-12-09
Completion:
2023-08-15
Conditions
  • Metastatic Nasopharyngeal Carcinoma
  • Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
  • Metastatic Nasopharyngeal Nonkeratinizing Carcinoma
  • Metastatic Nasopharyngeal Undifferentiated Carcinoma
  • Nasopharyngeal Nonkeratinizing Carcinoma
  • Recurrent Nasopharyngeal Carcinoma
  • Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma
  • Recurrent Nasopharyngeal Undifferentiated Carcinoma
  • Stage IV Nasopharyngeal Carcinoma AJCC v8
  • Stage IVA Nasopharyngeal Carcinoma AJCC v8
  • Stage IVB Nasopharyngeal Carcinoma AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
NCT03335995 | COMPLETED
364 participants

Stroke Prognosis in Intensive CarE

Study Type:
OBSERVATIONAL
Last Updated:
2025-10-03
Start Date:
2017-10-18
Completion:
2019-11-18
Conditions
  • Acute Stroke Patients Requiring Invasive Mechanical Ventilation
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page